Christchurch mutation points to potential gene therapy avenue for Parkinson's

A new OHSU study finds that the rare APOE Christchurch mutation may protect against Parkinson’s disease and Lewy body dementia by preventing alpha-synuclein buildup in mouse models. The research expands earlier Alzheimer’s findings and points toward a possible future gene therapy strategy.